π Title: The Need for Establishing Best Practices and Gold Standards in Psychedelic Medicine
π₯ Authors: Allison Feduccia, Gabby Agin-Liebes, Collin M. Price, Nicole Grinsell, Summer Paradise, David M. Rabin
π Link: https://doi.org/10.1016/j.jad.2023.03.083
π§ Summary: This review outlines the current lack of standardized protocols across psychedelic clinical research and therapeutic practices, emphasizing the urgent need for consensus on training, dosing, outcome measures, safety monitoring, and integration. Drawing from trials involving psilocybin, MDMA, and ketamine, the authors argue for a systematic framework to ensure efficacy and safety as psychedelics move closer to clinical mainstream.
π Results: The paper synthesizes existing literature and highlights heterogeneity in trial methodology, therapist training, and assessment tools. It identifies critical domains that need standardization, including preparatory sessions, psychological support, integration protocols, and long-term follow-up.
β Conclusion: As psychedelic therapies advance toward approval and widespread clinical use, establishing best practices and gold standards is vital. Doing so will protect patients, improve research comparability, and enhance the credibility of psychedelic-assisted therapies in psychiatric medicine.